Gjalt W. Huisman,Jed Lee Hubbs,Xiyun Zhang,Robert Osborne
申请号：
US15504134
公开号：
US20170273978A1
申请日:
2015.08.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides kinase inhibitor analogs with improved properties, such as improved efficacy, pharmacokinetics, safety, and specificity. In some embodiments, the present invention provides nilotinib analogs that provide therapeutic benefits.
